INTRODUCTION
Skeletal muscle is formed through the differentiation and fusion of myoblasts into a multinucleated syncytium. During this process, there are dramatic changes in the programs of gene expression that lead to the creation of the highly organized cytoskeletal apparatus of the muscle fiber. The myosin heavy chain (MyHC) protein is the major component of the thick filament and the most abundant protein of the sarcomere. It is responsible for converting chemical energy into mechanical force.
There are seven known sarcomeric MyHC isoforms expressed in skeletal muscle in mammals and an additional one expressed almost exclusively in the heart (reviewed in Weiss and Leinwand, 1996) . An individual gene encodes each isoform, and these genes are clustered in two genomic loci. The locus on chromosomes 14 in mice and humans contains the two genes expressed in the heart, ␣ and ␤ (Saez et al., 1987) , with the ␤ isoform also being expressed in slow type I skeletal muscle fibers. The cluster on chromosome 11 in mouse, and 17 in humans, contains the two developmental genes (embryonic and perinatal), the three adult fast genes (IIa, IId/x and IIb), and the extraocular gene expressed in extraocular and pharyngeal muscles (Leinwand et al., 1983; Weiss et al., 1999b) . The three adult fast genes are tightly linked, with the IIa and IId/x genes being separated by ϳ5 kb (Parker-Thornburg et al., 1992) . More recently, it has been shown that all six genes reside on a 350-kb segment of DNA in both mouse and human genomes (Weiss et al., 1999b) .
There is high homology exhibited by MyHC isoforms across different species, and the eight sarcomeric MyHC genes also have high identity at the amino acid level within an organism, ranging from 78 to 93% (Weiss and Leinwand, 1996) . While the biochemical properties of the ␣ and ␤ cardiac MyHCs have been well characterized, little is known about the functional properties of the remaining six striated muscle MyHC genes. Although the majority of the molecule is highly conserved, there are two highly variable regions or loops in the head, or motor domain. These loops are found near the actin binding and ATPase domains of the head and in vitro studies have implicated them in ATPase activities (Uyeda et al., 1994) . The three adult fast isoforms (IIb, IId/x, and IIa) are 93% identical, but fibers expressing them have clear differences in their ATPase histochemical staining properties and contractile features, and variability in their loop sequences suggests functional diversity (Weiss et al., 1999a) .
The three adult fast isoforms constitute the vast majority of the MyHC expressed in adult skeletal muscle in the mouse and other mammals. Along with a fiber-specific program of expression, they are thought to contribute to the nature of the contractile features of the fiber. In the mouse, the most abundantly expressed of these is the IIb isoform, constituting Ͼ70% of the total MyHC and up to 90% of that expressed in muscles such as the gastrocnemius and the quadriceps (Jansen et al., 1996) . The IId/x and IIa isoforms constitute most of the remaining MyHC expressed in mouse skeletal muscle. MyHC IId/x and IIa are abundantly expressed in a subset of muscles, such as the diaphragm and the soleus.
Skeletal muscle fibers are typed according to the MyHC isoform they express. For instance, IIB, IID/X, IIA, and I fibers contain IIb, IId/x, IIa, and I/␤ MyHCs, respectively. The fiber composition of a muscle is influenced by mechanical, neural, and hormonal factors (Roy et al., 1985; Ianuzzo et al., 1977; Nwoye and Mommaerts, 1981 ; reviewed in Pette and Staron, 1997) . In response to these stimuli, there is a transition of isoform expression following the pattern IIb 7 IId/x 7 IIa 7 I/␤, with evidence of hybrid fibers coexpressing IIb and IId/x, IId/x and IIa, and IIa and I/␤ that probably represent transitional stages for fiber conversion (see Staron and Pette, 1993) . The direction and extent of transitions are dependent on the stimulus. The mean cross-sectional area of a fiber is also fiber-type specific with the type IIB fibers typically being the largest of skeletal muscle fibers and type I/␤ being the smallest. Metabolically, IIB fibers are typically the most glycolytic and the type I/␤ fibers are the most oxidative (Hamalainen and Pette, 1993) . This spectrum of behavior is also reflected in the speed of contraction and ATPase activity in which IIB fibers are the fastest and type I, the slowest. Much of this is thought to be due to the ATPase activity of the MyHC expressed in these fibers (Reiser et al., 1985) , although there may be functional contribution from the other components of the sarcomere (Larsson et al., 1993; Schiaffino and Reggiani, 1994) .
Although the distinct biochemical properties of each isoform are still unknown, they appear to be necessary and to have different functions, as seen in gene targeting experiments with MyHCs IId/x and IIb (Acakpo-Satchivi et al., 1997; Sartorius et al., 1998) . Homozygous null mice for either IIb or IId/x have strong phenotypic abnormalities, which are strikingly distinct from each other. These different abnormalities are apparent both histologically and physiologically. Both null strains of mice appear to have normal amounts of MyHC. IId/x null mice exhibit compensation by the IIa gene, which is located 5 kb upstream of it on the chromosome (Sartorius et al., 1998) . Despite the fact that the IIa protein is 94% identical to IId/x, its induction in IId/x null animals does not result in normal muscle structure and function (Sartorius et al., 1998) . MyHC IIb null mice appear to exhibit compensation by both MyHC IIa and IId/x, but have very strong pathologic phenotypes including significant fiber hypertrophy and degeneration (Allen et al., in preparation) . To fully understand and appreciate the phenotypes of the null mice and MyHC gene expression in the normal mouse, it is important to determine, in detail, the patterns of expression of the adult fast MyHC genes.
The precise temporal and spatial timing of expression for the MyHC isoforms in the mouse have not been extensively documented. This kind of detailed analysis has been carried out in rabbit and rat, but it is clear that there is significant species variation (Homalainen and Pette, 1993) . Within the muscle differentiation program, a pair of developmental MyHC mRNAs precedes the appearance of the predominant RNAs seen in the adult (Lyons et al., 1990) . In situ hybridization analysis demonstrated the appearance of the embryonic and ␤-MyHC isoforms mRNAs sequentially beginning at 9.5 dpc, with perinatal appearing within the next 24 h (Lyons et al., 1990) . Using RNase protection analysis on limb muscles from 15 dpc, 18 dpc, birth, and 5 days after birth, Weydert et al. demonstrated that expression of the two developmental forms is predominant before and at birth and that the IIb isoform is barely detectable in hindlimb muscles at 18 dpc (Weydert et al., 1987) . Expression of other MyHC genes, including IIa and IId/x, was not examined in that study. Another study using gene-specific probes did not detect expression of adult MyHC mRNAs in diaphragm, masseter, tongue, or lower leg muscle at 17 dpc or at birth, but expression was seen at 5 days after birth, the next time point examined (Parker-Thornburg et al., 1992) .
In the present study we employed RNase protection on whole embryos and on neonatal muscles to determine when the expression of each MyHC gene is first detectable and their relative levels of expression as a function of development. In situ hybridization was also carried out to examine the locations of individual MyHC gene expression. In a previous study, we demonstrated expression of all three adult fast genes in 3-day-old leg muscle RNA by RT-PCR using 25 cycles of amplification (Sartorius et al., 1998) . We show here that the expression of the adult isoforms is detectable as early as 13.5 dpc by RNase protection, and by in situ hybridization the expression is strong in many but not all developing muscles between 15 and 17 dpc. The levels and distribution of expression for each of the three adult isoforms are not uniform in all the developing and neonatal musculature. In addition to RNA analysis, immunohistochemistry was carried out on neonatal muscles at 1, 3, and 5 days of postnatal life. RNA expression and protein expression appeared entirely coincident.
MATERIALS AND METHODS

RNA probes.
A 184-bp RT-PCR product was amplified from mouse heart RNA using primers 5Ј-ACCCAGAAGACTGTGGA-TGG and 5Ј-ATCCACGACGGACACATTG designed from published mouse GAPDH sequence (GB, M32599) and cloned into PCRScript (Stratagene) in which the T3 RNA polymerase makes the antisense riboprobe when linearized with BamHI. Similarly, a 144-bp fragment corresponding to the MyHC-IIa 3ЈUTR was amplified from skeletal muscle RNA using 5Ј-AAGCGAAGAGTAAGGCTGTC and 5Ј-GTGATTGCTTGCAAAGGAAC and cloned into PCR-Script. The linearized plasmid using EagI yields an antisense riboprobe with the T7 RNA polymerase. Linearization of at the BamHI site yields the sense riboprobe with the T3 RNA polymerase. The MyHC-IIb and IId/x probes were cloned previously by Dr. Leslie Acakpo-Satchivi by PCR from genomic DNA in which the products were cloned into the EcoRV site of pSK (Stratagene). The MyHC-IIb probe corresponds to a 121-bp fragment amplified by 5Ј-ACAAGCTGCGGGTGAAGAGC and 5Ј-CAGGACAGTGACAAAGAACG and linearization with EcoRI and transcription using the T7 promoter produces the antisense riboprobe. Linearization at the HindIII site and transcription using the T3 promoter produces the sense probe. The MyHC-IId/x riboprobe was subcloned from the original genomic clone using a SacI-HindIII digest cloning it into pKS, resulting in the loss of 60 bp of mouse genomic sequence with 106 bp corresponding to the 3ЈUTR. This clone yields an antisense riboprobe when linearized with HindIII and transcribed with T7 RNA polymerase. Sense riboprobes are transcribed with T3 RNA polymerase after linearization at the SacI site with subsequent blunting of the overhang.
RNA preparation. Mice were sacrificed and embryos were dissected in PBS on ice. At 15 dpc and later, embryos for RNA had brain and abdominal organs removed. Embryos were frozen in liquid nitrogen and stored at Ϫ80°C until RNA preparation. Neonatal masseters with cheek bones, upper limbs including shoulder/ scapula, and lower legs excised at the knee joint were separately frozen in liquid nitrogen. RNA was prepared by direct addition of RNA Inc.) to the samples with immediate homogenization using a Tissuemizer. RNA was prepared and resuspended in MilliQ water according to the manufacturer's instructions and stored at Ϫ70°C until analysis.
RNase protection. Riboprobes were labeled using [␣-32 P]UTP and for some probes [␣- 32 P]CTP (Andotek). The conditions of labeling were 25 Ci (at approx 3000 Ci/mmol) of radioactive NTP with 400 M nonradioactive NTP for the GAPDH (normalizing probe). For the MyHC probes, 80 Ci (approx 3000 Ci/mmol) of [␣- 32 P]UTP with 20 M nonradioactive UTP was used in the reaction. For double labeling, 70 Ci (approx 3000 Ci/mmol) of [␣ 32 P]UTP and 60 Ci (approx 3000 Ci/mmol) of [␣-32 P]CTP with 20 M nonradioactive UTP and CTP were used in the reaction. The nonlabeled NTP concentration was 300 -500 M. Reactions were run in 20 -25 l using T7 RNA polymerase (Gibco BRL). The reactions were carried out for 2 h at 37°C, then DNase I (Gibco BRL) was added to each tube and incubated for 30 min at 37°C. The reactions were then phenol:chloroform extracted and ammonium acetate precipitated. The pellet was resuspended in 20 l of stop buffer (95% formamide, 0.025% xylene cyanol, 0.025% bromophenol blue, 0.5 mM EDTA, 0.025% SDS), heated at 95°C for 5 min, and loaded onto a 3.5% acrylamide/8 M urea gel for gel purification. The probe was eluted in 200 l of 0.2 M sodium acetate, pH 4.0, 25 mM EDTA, 0.1% SDS overnight. The elution buffer was separated from the gel and the probe was precipitated and resuspended in water and the specific activity of the probe was determined.
The protection reaction was run using the RPA II kit (Ambion) with some adaptations (Mironov et al., 1995) . The amount of total RNA in a reaction varied from 6 to 10 g of RNA as assayed by the absorbance at 260 nm. Depending on the final volume necessary for the reaction, 2-2.5 l of 4ϫ aqueous hybridization buffer/4 ϫ PES (100 mM Pipes (pH 6.8), 4 M NaCl, 4 mM EDTA) was added. A 4-to 30-fold molar excess of riboprobes, or approximately 2-10 pmol of probe (Ͼ4 ϫ 10 5 cpm) and approximately 10 -20 pmol of the GAPDH probe, was added to the reaction in a total volume of 8 -10 l. The reactions were incubated at 90°C for 90 min in a hybridization oven and then centrifuged briefly and resuspended in 100 l of RNase digestion buffer with or without the addition of the RNase cocktail (Ambion) (final concentration of 2.5 units/ml RNase A and 100 units/ml RNase T1). The RNase digestion was incubated for 30 min at 37°C and 150 l of RNase Inactivation/ Precipitation mixture (Ambion) was added to each reaction, mixed, and placed at Ϫ20°C overnight. The reactions were spun at 13,000g for 30 min at 4°C, then separated on an 8% acrylamide (19:1), 8 M urea gel. The gel was run at 70 W for 1.5 h, fixed, and dried using a vacuum dryer. The dried gel was exposed overnight on a phosphoimager cassette.
Analysis of the amount of protected MyHC transcript was performed by normalizing the signal to that of GAPDH. This was corrected for the length and base content of the particular probe to get the absolute value of MyHC versus GAPDH. The absolute values for the six probes were then totaled and used to determine the percentage of each MyHC in the total.
In situ hybridization. Embryos were fixed in 4% paraformaldehyde in PBS, dehydrated, and infiltrated with paraffin. Sections of 5 to 7 m were cut. Hybridization and posthybridization procedures were performed as described in Lyons et al. (1990) . Probe preparation and labeling for the in situ hybridization were performed as described in Lyons et al. (1990) . MyHC IIa, IId/x, and IIb were prepared for labeling as described under RNA probes (see above).
Immunohistochemistry. Sections from the same postnatal tissue blocks used for in situ hybridization were also processed for immunohistochemistry. Unfixed, frozen sections (10 m thickness) were air dried for 10 min and circled with a hydrophobic PAP pen. Sections were then blocked for 60 min at room temperature in a blocking solution containing 0.1% bovine serum albumin (Sigma), 0.1% nonfat dry milk, 5% donkey serum, 0.01% Triton X-100, and 0.1 mg/ml unlabeled FAB antibody fragments (Jackson Immunochemicals). After several rinses in PBS, sections were incubated in primary antibody solution overnight at 4°C. The primary antibodies used were as follows: monoclonal anti-type I MHC (Novocastra) diluted 1:20; monoclonal antibody SC-71, which recognizes type IIA MHC, used undiluted as hybridoma supernatant; and monoclonal antibody BF-F3, which recognizes type IIB MHC, hybridoma supernatant diluted 1:2. Negative control sections receiving no primary antibody were consistently negative (not shown). Primary antibody was rinsed off with several rinses with PBS and then secondary antibody was added for 1 h at room temperature (goat anti-mouse IgG peroxidase conjugate for anti-types I and IIA and goat anti-mouse IgM peroxidase conjugate for IIB or goat anti-mouse IgM peroxidase conjugate for BF-F3). After several rinses in PBS, sections were stained using a DAB staining kit (Vector Laboratories) with nickel enhancement for 1-3 min. Sections were rinsed several times in PBS and mounted in 100% glycerol.
RESULTS
Embryonic Expression of MyHC Genes
To investigate the onset of "adult" fast MyHC mRNA expression, RT-PCR was performed. Using total embryo RNA at 15.5 and 17 dpc as a template, expression of MyHC IIa, IIb, and IId/x RNAs is detectable using 30 cycles of amplification (data not shown) and primers and conditions previously described (Sartorius et al., 1998) . Based on this observation, in situ hybridization was performed to localize this expression and RNase protection was performed to obtain quantitative information about the expression levels. Probes corresponding to the 3Ј untranslated region were used because of their predicted isoform specificity. The specificity of the embryonic, perinatal, and ␤ MyHC probes has been previously demonstrated (Lyons et al., 1990) and that of the IIa, IIb, and IId/x was determined by hybridization to adult skeletal muscles of known fiber composition (data not shown).
Expression of the MyHC IIb RNA was easily detectable by in situ hybridization in 15.5-dpc mouse embryos (Fig. 1) . Frontal sections were made through the head and abdomen along with a transverse section of forelimb (Figs. 1A and 1B) and hindlimb (Figs. 1C and 1D) . Hybridization with a probe for perinatal MyHC, used as a positive control, demonstrated localization in the developing tongue, masseter, abdominal, and forelimb muscles (Figs. 1A and 1C) . Many of these developing muscles also coexpressed the IIb RNA at this time point (Figs. 1B and 1D ). Highest expression levels of the IIb RNA were seen in the tongue and other head musculature such as masseter and facial muscles (Fig.  1B) . Forelimb and abdominal sections were also positive (Fig. 1B) . Hindlimb sections had a relatively weak signal for IIb at 15.5 dpc (Fig. 1D ). Low levels of MyHC IIb RNA expression were also detectable in the thoracic region, including the diaphragm (Fig. 2B vs 2A) while the sense control showed only scattered background (Fig. 2C) . At 16 dpc IIb RNA expression increased in the shoulder and forelimb musculature (Fig. 3) .
The transcripts of all three adult fast MyHC genes were detectable by in situ hybridization by 16.5 dpc (Fig. 4) . This was apparent in serial sections of the thorax demonstrating hybridization signals in intercostal muscles. As previously reported, the ␤ MyHC RNA is present in the developing skeletal musculature (Lyons et al., 1990) (Fig. 4D ). There was positive hybridization for IIa and IId/x RNAs as well as a strong signal for IIb RNA. All fiber compartments expressing ␤ RNA also appeared to express IIb RNA, in contrast to IIa and IId/x RNAs, which have a more restricted pattern of expression. Although the weakest signal of the three adult isoforms appeared to be IIa RNA in the samples before 17 dpc, its expression was clearly increased by 17.5 dpc in facial muscle (Fig. 5) . It thus appears that the IIb MyHC RNA is expressed at appreciable levels in many places in the embryo by 15.5 dpc and that expression followed a rostral/caudal gradient during development. As determined by in situ hybridization, the expression of MyHC IIb RNA preceded that of IId/x and IIa.
Because in situ hybridization gives primarily spatial data and is relatively insensitive compared to some other methods for RNA analysis, RNase protection was carried out to determine the earliest onset of expression and to determine relative levels of expression of all six skeletal MyHC genes. To increase sensitivity of the probes, labeling of the adult fast riboprobes with two isotopes was employed. Measurements were normalized to GAPDH and presented both as absolute values in terms of the concentration of a specific MyHC transcript per total RNA (as measured by the GAPDH signal) and as a percentage of total MyHC mRNA. Results of these analyses are presented in Table 1 and Fig. 6 . In RNA prepared from whole embryos at 13.5 dpc, low levels of IIb and IId RNA were detectable in the embryo (IIb, 0.03 Ϯ 0.01; IId/x, 0.02 Ϯ 0.004). These signals were minor (40ϫ lower) compared to those of the embryonic isoform (1.27 Ϯ 0.70) as well as of ␤ (0.23 Ϯ 0.08). Expression of the IIa gene was undetectable by RNase protection at 13.5 dpc. At 15 dpc, all three adult MyHCs, IIb, IIa, and IId/x, were detectable, but absolute values per microgram of total RNA for IIb and IId/x were not significantly different than at 13.5 dpc. By late gestation (19 dpc) the three adult fast mRNAs still represented a small fraction (IIb, 0.34%; IId/x, 0.44%; and IIa, 0.30%) of the total skeletal MyHC gene family expression. There appeared to be no dominant MyHC gene expressed among these three adult fast genes when whole-embryo RNA was examined. However, there were dramatic increases in the expression of the perinatal and ␤ MyHC genes between 15 and 19 dpc (Fig. 6) .
FIG. 4.
In situ hybridization on sections from 16.5-dpc mouse embryos depicting intercostal and chest (pectoralis) muscles. Expression of MyHC IIa (A), IIb (B), and IId/x (C) was detectable. The same developing musculature also coexpresses ␤ MyHC (D). The expression of MyHC IIa and IId/x is more restricted than that of MyHC IIb.
Postnatal Expression of Skeletal MyHC Genes
Expression of MyHC mRNAs was examined in postnatal samples by RNase protection and by in situ hybridization at different time points and in different muscles. Frontal sections through the heads of 1-, 3-, and 5-day-old mice were hybridized to probes for the following MyHC RNA genes: perinatal, IIa, IIb, IId/x, and ␤. Results for perinatal, IIa, IIb, and IId/x are shown in Fig. 7 . Perinatal MyHC was evenly distributed in all muscles of the head and showed strong signals at 1 and 3 days with decreasing intensity by 5 days. Expression of each of the three adult fast genes was distinct. IIa RNA was localized throughout the masseter with more expression in the medial region. Expression in the tongue was largely restricted to the periphery at 3 days and then assumed a more diffuse distribution by 5 days. In contrast, expression of IIb RNA was similar to that of perinatal, showing broad distribution in all muscles. Expression of IId/x RNA was strong in the tongue and much weaker in masseter, but only at 5 days.
FIG. 5.
In situ hybridization on 17.5-dpc mouse embryos. MyHC IIa expression has increased as shown on this section from the head and neck region, particularly in the masseter muscle. Localized expression within neck and intercostal muscles is also visible.
TABLE 1
Expression Levels of the Six Skeletal MyHC Genes in Development
Note. (A) Absolute levels of MyHC mRNA from wild-type mouse embryo (13.5, 15, and 19 dpc), neonatal leg and masseter, and adult masseter are shown as means (n ϭ 3) Ϯ SE (standard error of the mean). ND, not determined. (B) Relative amounts of each skeletal MyHC from wild-type mouse embryos (15 and 19 dpc), neonatal leg and masseter, and adult masseter are shown as means (n ϭ 3) Ϯ SE. The same time points were analyzed for muscles of the hindlimb. Results are shown in Fig. 8 . At all time points, perinatal RNA was broadly distributed. The most intense IIa signal was localized to the soleus, growing in intensity with time, but there was faint signal in other muscles. Once again, expression of IIb RNA was more broadly distributed but was most intense in the anterior compartment muscles (tibialis anterior, extensor digitorum longus) and the superficial portion of the gastrocnemius. IId/x RNA appeared to follow a distribution similar to that of the IIb RNA with high signal in all muscles but the greatest intensity was in the gastrocnemius, plantaris, and tibialis anterior (TA) muscles. For both IIb and IId/x RNA, the signal was weakest in the soleus muscle.
To provide quantitative information about RNA levels, hindlimb and masseter muscle RNA samples were isolated from neonatal animals and examined using the same panel of MyHC 3ЈUTR probes. In the time period between days 1 and 3 of postnatal life, significant quantitative changes in MyHC mRNA levels were evident (Fig. 9) . At birth, the muscles contained in the lower 1/3 between the knee and the ankle demonstrated an abundance of perinatal RNA compared to embryonic mRNA (Fig. 9) . Perinatal RNA was the predominant MyHC RNA expressed at both days 1 and 3 of postnatal life, representing 71.5 and 76% of the total MyHC, respectively. Among the three adult fast isoforms, the IId/x and IIb isoforms represented 1.99 and 1.23% of total MyHC RNA, respectively, while MyHC IIa was the least abundant at day 1, constituting 0.75% of the total. By the third day after birth, embryonic MyHC transcript levels decreased from 20 to 3% of total MyHC. Expression of the three adult fast mRNAs was clearly increased during this period. The level of MyHC IIb mRNA increased almost 20-fold from that detected at 1 day of postnatal life, with increases of 4-to 5-fold for MyHC IIa and IId/x mRNA. These increases in absolute amount were reflected by increases in IIb, IId/x, and IIa to 4.5, 5.0, and 1.0% of total MyHC mRNA. ␤ MyHC also showed dramatic increases in concentrations between these two time points.
MyHC mRNA levels were measured in masseter muscle isolated from neonates at 1 and 5 days after birth (Fig. 10) . As in the leg tissue, newborn masseter displayed levels of perinatal MyHC transcripts that were 3-to 5-fold higher than those of embryonic MyHC, and these mRNAs were the dominant isoforms expressed during the first neonatal week (8.03 Ϯ 1.16 and 2.51 Ϯ 0.96). Perinatal MyHC expression, which amounted to over 70% of the MyHC, not only persisted but the amount per microgram of total RNA increased between 2.5-and 5-fold (39.84 Ϯ 14.69) between the first and the fifth days, while the embryonic MyHC signal increased by approximately 2-fold. However, the relative percentage of perinatal MyHC increased only slightly, from 72 to 77%, because of changes in the expression of the other MyHC genes. Embryonic MyHC RNA as a percentage of the total decreased from 20.5% at day 1 to 15.7% of the total MyHC at 5 days. ␤ MyHC RNA, which was expressed in developing and in some adult musculature, remained approximately 4% throughout this time period, although its absolute amount increased. IId/x RNA expression rose 2-fold from 0.209 Ϯ 0.039 to 0.513 Ϯ 0.054 during the first neonatal week. This represented close to 2% of the total MyHC expressed in the masseter and decreased to just over 1% by 5 days. The amounts of IIa and IIb RNA expressed per microgram increased 7-to 10-fold between 1 and 5 days. However, the relative percentage increase does not reflect this degree of activation, with the MyHC IIa transcript increasing from about 0.4 to 1.05%, while the relative amount of MyHC IIb decreases slightly during this growth phase (0.18 to 0.14%). Comparison of MyHC mRNA expression in adult masseter with neonatal samples demonstrated the significant shifts in MyHC isoform RNA expression that occur between birth and adult-
FIG. 7.
In situ hybridization of frontal sections of heads of 1-, 3-, and 5-day-old mice. The masseters (m) and tongue (T) are indicated. Perinatal RNA is expressed evenly at all time points (A,E,I). IIa RNA is expressed regionally in the tongue and masseter at day 1 and more diffusely at day 5 (B,F,J). IIb RNA is evenly expressed at all three time points (C,G,K). IId/x RNA signal is not detectable in masseter until day 5 and is strongly expressed in the tongue (D,H,L).
hood. Although IId/x and IIa constituted 77.9 and 3.08% of the MyHC, respectively, in the adult masseter, they were nearly equivalent in expression levels in the day 5 neonate. MyHC IIb also rose from less than 1 to 18% of the total between neonatal and adult periods. Low levels of perinatal MyHC were also detectable in adult masseter, equaling 1% of the MyHC RNA expressed. Very rapid and quantitative changes in MyHC RNA expression occurred in the developing skeletal muscle during the first few days of life and in the weeks following, leading to the adult MyHC expression profile.
Expression of MyHC Proteins in Postnatal Muscles
To determine whether results obtained for MyHC RNAs correlated with protein expression, we carried out immunohistochemistry on the head and hindlimb muscles of 1-, 3-, and 5-day neonatal animals. Using isoform-specific antibodies, sections were probed for expression of MyHCs, embryonic, perinatal, IIa, IIb, and ␤. There is no antibody specific to the IId/x isoform. Figures 11 and 12 show expression of IIa, IIb, and type I isoforms in day 3 for the head and hindlimb muscles, respectively. In all cases, RNA and protein expression patterns overlapped. Embryonic and perinatal MyHC proteins were broadly distributed throughout the muscle sections (data not shown). In the head musculature, types I and IIA MyHC proteins were seen only in a few fibers in the deep portion of the masseter muscle (Fig. 11) . Type IIB MyHC protein was evident in both the masseter and the tongue at birth and increased in staining intensity across the first 5 days of postnatal development (Fig. 11) . In the hindlimb, type I MyHC protein was present in scattered fibers in all muscles throughout the first 5 days of development and was most prominent in the soleus. Type IIA MyHC protein was first expressed in soleus and in the deep portion of the TA at about 3 days postnatally,
FIG. 8.
In situ hybridization of cross sections through the hindlimbs of 1-, 3-, and 5-day-old mice. Individual muscles are indicated as follows: TA, tibialis anterior; EDL, extensor digitorum longus; Plt, plantaris; MG, medial gastrocnemius; Sol., soleus; LG, lateral gastrocnemius; Fib. and Tib., fibula and tibia, respectively. Perinatal RNA is expressed evenly at all time points, diminishing in signal somewhat by day 5 (A,E,I). IIa RNA is strongly expressed in the soleus and then more faintly in most other muscles (B,F,J). IIb RNA is initially evenly distributed but most intensely expressed in the anterior compartment muscles (C,G,K). IId/x and IIb RNA are similarly distributed (D,H,L). while type IIB MyHC was also first seen at 3 days postnatal, in the superficial aspects of the gastrocnemius and TA muscles (Fig. 12) .
DISCUSSION
MyHC is among the first of the sarcomeric proteins expressed by a differentiating myoblast and thus has been used as a marker for muscle differentiation that, along with other structural proteins, forms the first filamentous structures of the sarcomere (see Fulton and Alftine, 1997) . The isoforms expressed at this early time, such as embryonic and perinatal MyHC, may play a role in the formation of the sarcomere and to a lesser extent in the force production of the sarcomere. In the mature fiber, the adult MyHC isoform defines, in part, the force and velocity characteristics of that fiber (Reiser et al., 1985) .
Much of our understanding of the developmental and physiological responses of the MyHC gene family has come from studies in rats, birds, and rabbits. Larger vertebrates clearly differ in their MyHC content compared to the mouse (Hamalainen and Pette, 1993) . The advent of transgenic technology has made the mouse a better genetic organism for studying disease and development, and therefore MyHC expression patterns need to be established in the mouse. For example, genetic inactivation of adult fast IId/x or IIb MyHC genes results in mice with severe and distinct phenotypes (see Akacpo-Satchivi et al., 1997; Sartorius et al., 1998) . To better define the expression of skeletal MyHC isoforms in the mouse, we have examined MyHC RNA and protein expression prenatally and in the first days of postnatal life. These studies demonstrate that the adult genes in the mouse are expressed as RNA at an earlier stage in development than previously reported and document the rapid changes in MyHC gene expression and spatial distribution that occur in development and in postnatal life.
Early expression studies suggested a scheme of MyHC gene expression in myogenesis. Rat primary myotubes express the embryonic MyHC isoform first (Condon et al., 1990) , and the majority of them subsequently coexpress the perinatal and ␤/slow MyHC isoforms . The expression of either the perinatal or the ␤ MyHC isoform is subsequently lost (Condon et al., 1990) , marking the fate of the fiber to become fast or slow, respectively (Gunning and Hardeman, 1991) . Most of these primary fibers appear to mature into slow fibers (Kelly, 1980; McLennan, 1983) . Fiber formation from secondary myoblast fusion into myotubes begins after the appearance of these primary fibers (Condon et al., 1990; Harris et al., 1989) . All secondary myotubes initially express embryonic and subsequently perinatal MyHC . Some of these secondary forming fibers may commit to expressing ␤ MyHC, possibly marking the decision of fiber fate (Gunning and Hardeman, 1991) . Much of the work described above has been carried out in organisms other than mouse, such as rat and rabbit. In the mouse, RNA analysis of the IIa and IId/x genes suggested that the adult fast isoforms are not expressed until late in gestation (18 dpc for IIb) or after birth (IIa and IId/x) (Weydert et al., 1987) . These earlier studies were limited to some extent by the sensitivity of the probes. Using larger probes and conditions to boost the specific activity of the probe for the RNase protection studies, as well as using in situ hybridization, our studies demonstrate that developing muscle appears to initiate expression of adult isoforms earlier than suggested by these previous studies.
As analyzed by in situ hybridization, the expression of
MyHC IIb progressively appears in most if not all of the developing skeletal muscle, and it appears to be the most robustly expressed of the three adult fast isoforms in the embryo. This is similar to the expression pattern in the adult mouse in which the IIb isoform is the most abundantly expressed isoform in skeletal muscle, representing Ͼ70% of the MyHC mRNA in many adult mouse muscles. Detection of expression of IIb mRNA as assessed by in situ hybridization begins as early as 14.5 dpc and precedes the expression of the IId/x and IIa genes. The expression of all three fast genes is activated in a rostral to caudal fashion. Normally the fiber-type transition of adult muscle fibers proceeds from IIB 7 IID/X 7 IIA, with coordinate changes in MyHC gene expression. This transition from MyHC IIb to IIa expression appears to parallel the consecutive appearance of the adult fast MyHC genes in utero. The IIb and IId/x transcripts are low but detectable at 13.5 dpc as assessed by RNase protection. Each of the RNA samples individually analyzed appeared to have higher levels of the IIb transcript than the IId/x, although the difference is not statistically significant. IIa expression is undetectable at this time point. Our data suggest that the expression pattern of the three genes in early development is similar to the physiological switching that occurs during fiber type transition in the adult. It is conceivable that similar molecular mechanisms may underlie both phenomena. Multiple factors may be involved in activating the expression of the adult MyHC genes in the embryo. Innervation, calcium influx, and hormonal signals such as thyroid hormone have all been shown to affect the expression of the MyHCs as well as changing fiber-type gene expression (Whalen et al., 1985) . The appearance of MyHC IIb expression correlates temporally with secondary myotube and fiber formation, which also occurs at approximately 15 dpc. Neuronal influence may be important for these secondary fibers (Duxson et al., 1989) . Neurally derived signals could be responsible for initiating expression of the adult fast genes, although it is also possible that MyHC IIb expression may be independent of innervation. Most studies in the mouse embryo involving the expression of muscle proteins, including the MyHCs, have focused on detection of the RNA rather than the protein. For example, it was shown that the myogenin transcript is present in the mouse embryo at 10.5 dpc, but the protein is not detectable (Cusella-De Angelis et al., 1992) . A translational block in the adult MyHCs may be present and be regulated by external stimuli (i.e., innervation or growth factors) since we have been unable to detect the MyHC IIb protein by immunohistochemistry on 16-and 18-dpc embryos (unpublished observations). However, this may also be due to the weak affinity of the monoclonal antibodies. In support of the concordance of MyHC RNA and protein, a very thorough developmental study of MyHC mRNA and protein in rabbit suggested no apparent discordance between MyHC RNA and protein (McCoy et al., 1998) . In addition, our analysis of MyHC protein expression in postnatal samples suggested that MyHC RNA and protein are entirely coincident.
In the first few days after birth there are significant changes in the levels of the different MyHC transcripts. As expected, the perinatal isoform is the dominantly expressed isoform. A decrease in the expression of the embryonic MyHC RNA also occurs, but the amount varies between leg muscle and masseter. Interestingly, leg muscles appear to more rapidly decrease embryonic expression (20.0 to 2.9%) between days 1 and 3 in contrast to masseter muscle in that embryonic is still 15.7% of the total MyHC expressed at day 5. This is likely due to different functional requirements of neonatal muscles. The neonates utilize leg muscles, but the masseter is not used for chewing since they are on a liquid diet for 2 weeks after birth. In all neonatal samples, expression of the adult fast MyHC mRNAs increases as a function of time, although their relative percentages do not necessarily reflect this change. This is probably due to ongoing myogenesis, in which more immature myoblasts and myotubes are still differentiating through the developmental MyHC isoforms, and the smaller number of older existing fibers are converting to adult fast MyHC isoform expression. The ratios of the adult fast MyHC transcript levels, though, do not reflect those of the adult. If the induction of these adult mRNAs is reflective of maturing fibers expressing adult fast MyHC proteins, then the different MyHC fiber types may be forming and maturing at different rates in the neonate. Alternately, these maturing fibers may switch during the first few weeks of life in the expression of MyHC isoforms to result in the adult expression pattern.
This study suggests that factors necessary to activate adult MyHC isoform expression are present in the developing embryo. The regulatory regions that control individual MyHC gene expression and the possible regulation of the MyHC gene cluster are not known, nor is it known if there is a distinct pattern of activation of the MyHC genes in the cluster like that seen in other gene families. From the studies of other muscle-specific genes, it is not clear if there is a coordinated program of fast or slow fiber gene expression (Sutherland et al., 1991) . In the developing mouse, multiple factors may be necessary to fully coordinate a fiber-specific gene expression pattern at both the transcriptional and the translational levels.
